BK Clinical Trials Consulting K/S — Credit Rating and Financial Key Figures

BK Clinical Trials Consulting K/S (CVR number: 37105740) is a company from RUDERSDAL. The company recorded a gross profit of 1556.8 kDKK in 2024. The operating profit was 1552.3 kDKK, while net earnings were 1703.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 46 %, which can be considered excellent and Return on Equity (ROE) was 52.7 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 89.3 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. BK Clinical Trials Consulting K/S's liquidity measured by quick ratio was 9.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.